Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in a Xenopus oocyte expression system

Journal of Pharmacology and Experimental Therapeutics

Volumn 291, Issue 2, 1999, Pages 618-626

  Mcallister, Sean D ^a   Griffin, Graeme ^a   Satin, Leslie S ^a   Abood, Mary E ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ANANDAMIDE; CANNABINOID RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; POTASSIUM; POTASSIUM CHANNEL; RIMONABANT;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG INHIBITION; DRUG POTENCY; DRUG RECEPTOR BINDING; NONHUMAN; OOCYTE; POTASSIUM CURRENT; POTASSIUM TRANSPORT; PRIORITY JOURNAL; PROTEIN EXPRESSION; XENOPUS LAEVIS;

ANALGESICS; ANIMALS; ARACHIDONIC ACIDS; ASPARAGINE; CALCIUM CHANNEL BLOCKERS; CYCLOHEXANOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; GTP-BINDING PROTEINS; MORPHOLINES; MUTATION; NAPHTHALENES; OOCYTES; POLYUNSATURATED ALKAMIDES; POTASSIUM CHANNELS; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; RNA, COMPLEMENTARY; TIME FACTORS; XENOPUS;

EID: 0032696104     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Adams IB, Compton DR and Martin BR (1998) Assessment of anandamide interaction with the cannabinoid brain receptor: SR141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain. J Pharmacol Exp Ther 175:435-442.
2. Bausch SB, Patterson TA, Ehrengruber MU, Lester HA, Davidson N and Chavkin C (1995) Co-localization of mu opioid receptors with GIRK1 potassium channels in the rat brain: An immunocytochemical study. Recept Channels 3:221-241.
3. Bouaboula M, Perrachon S, Milligan L, Canat X, Rinaldi-Carmona M, Portier M, Barth F, Calandra B, Pecceu F, Lupker J, Maftrand JP, LeFur G and Casellas P (1997) A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interaction. J Biol Chem 272:22330-22339.
4. 2 peripheral cannabinoid receptor: Involvement of both mitogen-activated protein kinase and the induction of Krox-24 expression. Eur J Biochem 237:704-711.
5. Chan KW, Langan MN, Sui JL, Kozak JA, Pabon A, Ladias JA and Logothetis DE (1996) A recombinant inwardly rectifying potassium channel coupled to GTP-binding proteins. J Gen Physiol 107:381-397.
6. Compton DR, Rice KC, De Costa BR, Razdan RK, Melvin LS, Johnson MR and Martin BR (1993) Cannabinoid structure-activity relationship: Correlation of receptor binding and in vivo activities. J Pharmacol Exp Ther 265:586-594.
7. 9-tetrahydrocannabinol-induced responses and apparent agonist activity. J Pharmacol Exp Ther 227:586-594.
8. Dascal N, Lim NF, Wolfgang S, Weizhen W, Norman D and Lester HA (1993a) Expression of an atrial G protein-activated potassium channel in Xenopus oocytes. Proc Natl Acad Sci USA 90:6596-6600.
9. + channel: Expression cloning and molecular properties. Proc Natl Acad Sci USA 90:10235-10239.
10. + Channels. Cell Signal 9:551-573.
11. Devane WA, Hanua L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A and Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science (Wash DC) 258:1946-1949.
12. + channel activity of neuronal and cardiac G protein-activated inward rectifiers. Biochem Biophys Res Commun 212:657-663.
13. 2 receptors. Mol Pharmacol 48:443-450.
14. Galiegue S, Mary S, Marchand J, Dussossoy D, Carriere D, Carayon P, Bouaboula M, Shire D, Le Fur G and Casellas P (1995) Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 232:54-61.
15. Gaoni Y and Mechoulam R (1964) Isolation, structure and partial synthesis of an active constituent of hashish. J Am Chem Soc 86:1646-1647.
16. 35S]thio)-triphosphate binding assay in rat cerebellar membranes. J Pharmacol Exp Ther 286:553-560.
17. Hans-Jurgen K, Hans-Hinrich H and Dietmar R (1997) Coupling of rat somatostatin receptor subtypes to a G protein gated inwardly rectifying potassium channel (GIRK1). FEBS Lett 419:92-94.
18. Henry DJ and Chavkin C (1995) Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes. Neurosci Lett 186:91-94.
19. Herkenham M, Lynn AB and Rice KC (1991) Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study. J Neurosci 11:563-583.
20. Hille B (1992) Potassium channels and chloride channels, in Ionic Channels of Excitable Membranes (Hille B eds) pp 115-139, Sinauer Associates Inc., Sunderland.
21. Kenakin T (1996) The classification of seven transmembrane receptors in recombinant expression systems. Pharmacol Rev 48:413-451.
22. Kovoor A, Henry DJ and Chavkin C (1995) Agonist-induced desensitization of the mu opioid receptor-coupled potassium channel (GIRK1). J Biol Chem 270:589-595.
23. + channel proteins. Nature (Lond) 374:135-141.
24. 1 receptor. Eur J Pharmacol 334:R1-R2.
25. + channel determined by construction of multimeric cDNAs. Neuron 9:861-871.
26. + channel in the heart. Nature (Lond) 325:321-326.
27. Mackie K, Mitchell R and Westenbrook R (1995) Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT-20 cells transfected with rat brain cannabinoid receptor. J Neurosci 15:6552-6561.
28. Matsuda LA, Lolait SJ and Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature (Lond) 348:561-564.
29. Munro S, Thomas KL and Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature (Lond) 365:61-65.
30. Pan X, Ikeda SR and Lewis DL (1996) Rat brain cannabinoid receptor modulates N-type calcium channels in a neuronal expression system. Mol Pharmacol 49:707-714.
31. 1 cannabinoid receptor activity. Mol Pharmacol 54:1064-1072.
32. 2 receptors. Pharmacol Ther 74:129-180.
33. Pertwee RG and Griffin G (1995) A preliminary investigation of the mechanisms underlying cannabinoid tolerance in the mouse vas deferens. Eur J Pharmacol 272:67-72.
34. + channel proteins (GIRK1) are present in soma and dendrites as well as in nerve terminals of specific neurons of the brain. J Neurosci 15:1990-2001.
35. Pfaffinger PJ, Martin JM, Hunter DD, Nathanson NM and Hille B (1985) GTP-binding proteins couple cardiac muscarinic receptors to a K channel. Nature (Lond) 317:536-538.
36. Reuveny E and Jan LY (1994) Activation of the cloned muscarinic potassium channel by G protein βγ subunits. Nature (Lond) 370:143-146.
37. Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Neliat G, Caput D, Ferrar P, Soubrie P, Breliere JC and Fur GL (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350:240-244.
38. Shen M, Piser TM, Seybold VS and Thayer SA (1996) Cannabinoid receptor agonists inhibit glutaminergic synaptic transmission in rat hippocampal cultures. J Neurosci 16:4322-4334.
39. 2 adrenoceptor that blocks coupling to potassium but not calcium current. Science (Wash DC) 257:977-980.
40. 2 receptors disrupts G protein coupling. J Pharmacol Exp Ther 285:651-658.
41. 1 receptors in the rat central nervous system. Neuroscience 83:393-411.